Representative before the EPO

Company dna mintz levin cohn ferris glovsky and popeo llp
no operation time available
3 offices
active in Legal Services

Representative before the EPO

Employment test 51 - 200 employees
Company dna haseltine lake llp
no operation time available
Headquarter in Bristol and 6 offices
active in Legal Services and IP Consulting

Isobel Lara Finnie has worked on the following 42 EPO patent applications which have been published in the last five years:

EP11707328

COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN DISEASES AND DISORDERS USING ANTIMICROBIAL PEPTIDE SEQUESTERING COMPOUNDS

IPC classification:
A61K 31/66, A61K 31/685, A61K 31/70, A61K 31/715, A61K 31/716, A61K 31/721, A61P 17/00
Agent:
Ter Meer Steinmeister & Partner PartGmbB
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Isobel Lara Finnie, Mintz Levin Cohn Ferris Glovsky and Popeo LLP
Status:
EXAMINATION IN PROGRESS
EP12854522

PERSONALIZED PAIN MANAGEMENT AND ANESTHESIA: PREEMPTIVE RISK IDENTIFICATION AND THERAPEUTIC DECISION SUPPORT

IPC classification:
C07K 7/06, C12N 15/11, C12N 15/12, C12Q 1/68
Applicant:
Children's Hospital Medical Center
Agent:
Maiwald Patentanwalts GmbH
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION IN PROGRESS
EP13747279

A MULTI-BIOMARKER-BASED OUTCOME RISK STRATIFICATION MODEL FOR PEDIATRIC SEPTIC SHOCK

IPC classification:
C12Q 1/68, C40B 30/00, G01N 33/50, G01N 33/68
Applicant:
Children's Hospital Medical Center
Agent:
Regina Neuefeind, Maiwald Patentanwalts GmbH
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION IN PROGRESS
EP13746458

A MULTI-BIOMARKER-BASED OUTCOME RISK STRATIFICATION MODEL FOR ADULT SEPTIC SHOCK

IPC classification:
G01N 33/50, G01N 33/53, G01N 33/68
Applicant:
Children's Hospital Medical Center
Agent:
Regina Neuefeind, Maiwald Patentanwalts GmbH
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
PATENT GRANTED
EP13751420

ESOPHAGEAL MICRORNA EXPRESSION PROFILES IN EOSINOPHILIC ESOPHAGITIS

IPC classification:
C12N 15/11, C12Q 1/68
Applicant:
Children's Hospital Medical Center
Agent:
Regina Neuefeind, Maiwald Patentanwalts GmbH
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION IN PROGRESS
EP14189758

Antibodies directed to GPNMB and uses thereof

IPC classification:
A61K 39/00, A61K 39/395, A61K 47/48, A61P 35/00, C07K 16/28, C07K 16/30
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Status:
EXAMINATION IN PROGRESS
EP13798097

FREEZE-DRYING CONJUGATE-CONSTRUCT FOR POINT-OF-CARE TESTING IMMUNOCHROMATOGRAPHY, A KIT FOR IMMUNOASSAY USING THE SAME, AND A METHOD FOR ANALYSIS USING THE KIT

IPC classification:
G01N 30/02, G01N 33/53, G01N 33/532, G01N 33/538
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Status:
EXAMINATION IN PROGRESS
EP13742640

QUINONE COMPOUNDS AND THEIR USES FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/495, A61P 35/00, C07D 403/10
Agent:
Multiple attorneys, Haseltine Lake LLP
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Status:
GRANT OF PATENT INTENDED
EP13786660

BIOMARKER COMBINATIONS FOR COLORECTAL TUMORS

IPC classification:
C12Q 1/68
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Status:
EXAMINATION IN PROGRESS
EP14757651

METHODS OF TREATING OTOTOXICITY

IPC classification:
A61K 31/202
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14716187

SYSTEMS FOR SUSTAINED INTRAOCULAR DELIVERY OF LOW SOLUBILITY COMPOUNDS FROM A PORT DELIVERY SYSTEM IMPLANT

IPC classification:
A61K 9/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Catherine Louise Booth, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14721620

3-(ARYL OR HETEROARYL) METHYLENEINDOLIN-2-ONE DERIVATIVES AS INHIBITORS OF CANCER STEM CELL PATHWAY KINASES FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/433, A61P 35/00, C07D 401/14, C07D 403/06, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/04, C07D 417/14, C07D 471/04, C07D 487/04
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP11757135

NOVEL METHODS FOR TARGETING CANCER STEM CELLS

IPC classification:
A01N 43/16, A61K 31/35
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Multiple attorneys, Mintz Levin Cohn Ferris Glovsky and Popeo LLP
Status:
EXAMINATION IN PROGRESS
EP14728712

BIMATOPROST OCULAR SILICONE INSERTS AND METHODS OF USE THEREOF

IPC classification:
A61K 9/00, A61K 31/5575
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Catherine Louise Booth, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP11757134

NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS

IPC classification:
A01N 43/16, A61K 31/35, A61P 35/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Multiple attorneys, Mintz Levin Cohn Ferris Glovsky and Popeo LLP
Status:
EXAMINATION IN PROGRESS
EP15189243

ANTIBODIES AGAINST T CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN 1 (TIM-1) ANTIGEN AND USES THEREOF

IPC classification:
A61P 35/00, C07K 14/47, C07K 16/18, C12N 15/12
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14742552

TUMOUR-TARGETED THERANOSTIC

IPC classification:
A61K 47/48, A61K 49/18
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Applicant:
The University of Bradford
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP14832137

IDENTIFICATION OF SURGERY CANDIDATES USING NATURAL LANGUAGE PROCESSING

IPC classification:
G06F 17/30, G06Q 50/24
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP14790002

DEVICE

IPC classification:
A61F 13/15, A61L 15/22
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP16156340

COMPOSITIONS OF KINASE INHIBITORS AND THEIR USE FOR TREATMENT OF CANCER AND OTHER DISEASES RELATED TO KINASES

IPC classification:
A61K 31/427, A61P 35/00, C07D 209/34, C07D 417/02, C07D 417/14
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION IN PROGRESS
EP14786138

DEVICE

IPC classification:
A61F 13/00, A61F 13/02
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP14786137

DEVICE

IPC classification:
A61F 13/00, A61F 13/02
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP14851643

RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS

IPC classification:
A61K 31/436
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14854407

GENETIC MARKERS FOR ANTIPSYCHOTIC INDUCED WEIGHT GAIN AND METHODS FOR USE THEREOF

IPC classification:
C07H 21/00, C12Q 1/68, C40B 30/04, C40B 40/06, C40B 40/10, G01N 33/48
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
GRANT OF PATENT INTENDED
EP14853689

FORMULATIONS AND METHODS FOR INCREASING OR REDUCING MUCUS

IPC classification:
A61B 17/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Agent:
Catherine Louise Booth, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP16156278

NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT

IPC classification:
A61K 31/505, A61K 31/55, A61K 38/17, A61P 35/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14863430

TEMPORAL PEDIATRIC SEPSIS BIOMARKER RISK MODEL

IPC classification:
C12Q 1/68
Applicant:
Children's National Medical Center
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14873830

GENETIC MARKERS ASSOCIATED WITH SUICIDE RISK AND METHODS OF USE THEREOF

IPC classification:
C07H 21/04, C12Q 1/68, C40B 30/04, C40B 40/06, G06F 19/18
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14877182

GENETIC RECOMBINANT SACCHAROMYCES CEREVISIAE CAPABLE OF DEGRADING AND UTILIZING KITCHEN WASTES

IPC classification:
C12N 1/19, C12N 15/81, C12R 1/865
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP14876437

THE USE OF TRANSGENIC PLANT FOR RECOVERY OF NON-TRANSGENIC HYBRIDS

IPC classification:
A01H 5/00, A01H 5/10
Applicant:
The Board of Governors for Higher Education, State of Rhode Island and Providence Plantations
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
APPLICATION WITHDRAWN
EP15740043

APILIMOD COMPOSITIONS AND METHODS FOR USING SAME

IPC classification:
A61K 31/429, A61K 31/496, A61K 31/5377
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15706986

RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS

IPC classification:
A61K 9/00, A61K 9/12, A61K 31/436, A61K 31/70, A61K 47/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP16182813

NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS

IPC classification:
A01N 43/16, A61K 31/35, A61P 35/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION IN PROGRESS
EP15754639

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF ANTIPSYCHOTIC MEDICATION-INDUCED WEIGHT GAIN

IPC classification:
C12Q 1/68, G01N 33/50, G06F 19/10, G06F 19/12, G06F 19/18
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15707526

METHODS AND COMPOSITIONS FOR PERSONALIZED PAIN MANAGEMENT

IPC classification:
C12Q 1/68
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15740755

O-PHENYL CHALCONE COMPOUND AND PREPARATION METHOD AND USE THEREOF

IPC classification:
A61P 35/00, C07C 45/45, C07C 49/835, C07C 49/84, C07C 221/00, C07C 225/22, C07C 253/30, C07F 5/02, C07F 9/12
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15772788

NEW TRICYCLIC QUINONE DERIVATIVE

IPC classification:
A61K 31/381, A61K 31/4355, A61K 31/4365, A61K 31/5377, A61P 35/00, A61P 35/02, C07D 491/048, C07D 495/04
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15718687

AN INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS

IPC classification:
A61K 9/14, A61K 9/72, A61K 31/436, A61P 43/00
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15828951

DIAGNOSTIC METHOD FOR DISTINGUISHING FORMS OF ESOPHAGEAL EOSINOPHILIA

IPC classification:
C08K 5/521, C08K 7/06, C08L 69/00, C12Q 1/68, G01N 33/53
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15836301

COMPOSITION AND MEDICINAL PRODUCT FOR REDUCING BODY WEIGHT AND BODY FAT, AND USE OF SAID PRODUCT

IPC classification:
A61K 31/05, A61K 36/82, A61K 36/9066, A61P 3/04
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED
EP15836003

COMPOSITION FOR REDUCING LOCAL FAT AND BODY WEIGHT, AND PHARMACEUTICALS AND USE THEREOF

IPC classification:
A61K 9/06, A61K 9/08, A61K 9/70, A61K 31/05, A61K 36/9066, A61P 3/04
Agent:
Isobel Lara Finnie, Haseltine Lake LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature